Psychiatry

A 3-part series on the manifestations of physician burnout, how COVID-19 changed its scope and revealed systemic fractures, and finally, the path towards resolution and reformation.

Sharp candidly discusses the need for new solution ideas to strike while the iron is hot, during this rebuilding stage of the healthcare system.

A new study highlights the urgency to implement better access and distribution of naloxone to avert witnessed opioid overdose deaths.

Qbtech is hoping to address some gaps in testing and screening for the specific symptoms of ADHD in individuals aged 6-60.

Our third and final episode on physician burnout traces the path towards a solution and ultimately, reformation in the system as a whole.

The treatment met the pre-specified primary endpoint of significantly less weight gain in the ENLIGHTEN-Early trial.

There was an elevated risk of violence perpetration in both men and women with schizophrenia spectrum disorder.

Within the first year of the pandemic, total patients in the emergency department with a violent penetrating injury significantly increased—disproportionately so for people of color.

February 3 is National Women's Physician Day.

Our 5 experts return to examine the far-reaching repercussions of the COVID-19 pandemic on the physician burnout crisis.

Investigators observed significant increases in the rate of encounters with children and adolescents with autism spectrum disorder, as well as those with anxiety and depression.

Approximately 50% of individuals who commit suicide make a health care visit in the proceeding month.

Ineligible patients with schizophrenia have a higher risk of hospitalization for a number of reasons, including suicide attempts.

Joined by 5 experts in the field of burnout, Crisis Point uncovers the ways burnout manifests and the ramifications it has on both personal and professional lives.

A better understanding of this connection could yield preventative treatments.

MindMed will now move forward with the 200 patient randomized, placebo-controlled study.

Analysis of 2 national surveys suggest a more than two-fold greater likelihood of depressed Americans endorsing a false fact about COVID-19 vaccines than others.

Despite attempts climbing since 2008, investigators have observed no significant change in suicidal adults seeking care.

Brexipiprazole has been previously approved for adults with schizophrenia and adults with major depressive disorder.

Between 20-30% of patients with schizophrenia do not respond to the first-line antipsychotic treatment.

Several risk factors including low education and unhealthy lifestyle choices are partially responsible for this projected increase, though investigators believe changes could be made to decrease the number of dementia cases.

The University of Michigan School of Nursing DASH Center director discusses the impact and reach of adult prescription drug misuse.

A new survey analysis shows prescription opioid, stimulant, sedative and tranquilizer misuse is common by age 50, and is greatly associated with substance abuse disorder risk.

Previous research have focused mostly on adults or patients with other comorbidities.

Burnout problems persisted prior to the COVID-19 pandemic, but have been made worse since the beginning of the pandemic.